Here are 18 key notes on spine and orthopedic device companies.
Amendia acquired the iO-Flex and iO-Tome product lines and technology rights to add to Amendia's growing list of spinal surgical instruments.
Bacterin processed more than 1,000 lots of OsteoSelect DBM Putty, an operational milestone.
John East, DO, and Brandon Knutson, DC, established a new biomedical company BioTras, which offers a new medical training tool, the AsTris1.0 for spinal injections.
A new study shows that the Cerapedics i-FACTOR biologic bone graft could be an alterative to autograft during spine surgery.
Cytori Therapeutics announced that the first patient has been treated in its FDA-approved trial assessing the effect of Cytori Cell Therapy for knee osteoarthritis.
DJO Global reported net sales of $327.1 million during the fourth quarter of 2014, up 4.3 percent over the same period last year.
EOS imaging announced the installation of the EOS system at a private clinic in Lausanne, Switzerland.
Exactech reported revenue for 2014 was up 5 percent to $248.4 million.
Ferring Pharmaceuticals acquired the assets of BioSurface Engineering Technologies, including two phase III-ready orthobiologic product candidates.
Argus raised Integra Lifesciences' price objective from $55 to $61 in a research report.
LDR reported total revenue growth in the fourth quarter of 2014, which was up 23.6 percent over the same period last year, reaching $39.5 million.
Mazor Robotics reported more systems sold and utilization growth in 2014.
Medtronic reported worldwide revenues of $4.3 billion in the third quarter of the 2015 fiscal year as the company moves forward with its Covidien acquisition.
Orthocell announced that the first Hong Kong-based patients have been treated with its Ortho-ATI therapy, thereby expanding its presence in Asia.
Precision Spine entered into a financial agreement that will allow the company to refinance its existing debt, and it will the company will begin to actively target and pursue acquisitions in strategic markets.
Donald Kucharzyk, DO, showed the Precision Spine MD-Max ULIF System can achieve better outcomes over the traditional open spine surgery approach.
Simplify Medical received a CE mark for its Simplify Disc.
Vertex Pharmaceuticals recently acquired a spinal cord injury repair drug from BioAxome Bioseicneces.
More articles on devices:
8 key trends in the global arthroscopic devices market
Blue Belt reaches 1k surgeries with Navio Robotic Surgical System — 5 key notes
DJO's net loss down to $90.5 million in 2014 — 10 things to know